Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Nivolumab
Papillary Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Paraganglioma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Paranasal Sinus Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Placental Choriocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Plasmablastic Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Eccrine Porocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Primary Effusion Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Pseudomyxoma Peritonei
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Rectum Malignant Melanoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Squamous Cell Carcinoma Of Rectum
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Lymphomatoid Granulomatosis
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Thyroid Gland Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Scrotum Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Seminal Vesicle Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Seminoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Serous Cystadenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Sezary Syndrome
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Cutaneous Adenocystic Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Skin Appendage Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Basosquamous Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Showing 1776 to 1800 of 3,272 assets
PreviousPage 72 of 131Next